Earnings History Data for Verrica Pharmaceuticals (VRCA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Verrica Pharmaceuticals
Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2024 | AH | VRCA | Verrica Pharmaceuticals | 60.00 | -0.49 | -0.37 | 0.00 | Verrica Pharmaceuticals Non-GAAP EPS of -$0.43 misses by $0.04 [11/4/2024 5:48 PM] |
0.7976 | -0.63 (-44.22%) |
0.91 | -0.52 (-36.20%) |
0.75 - 11.41 | 3,456,507 | 350,000 | 139,001 | ||
| 14-08-2024 | PM | VRCA | Verrica Pharmaceuticals Inc. | 210.83 | -0.37 | -0.43 | -0.24 | Verrica Pharmaceuticals Non-GAAP EPS of -$0.31 beats by $0.09, revenue of $5.12M [8/14/2024 7:50 AM] |
3.11 | -2.16 (-40.94%) |
5.29 | 0.02 (0.38%) |
2.86 - 11.41 | 4,815,481 | 310,000 | 403,863 | ||
| 13-05-2024 | PM | VRCA | Verrica Pharmaceuticals Inc. | 332.56 | -0.44 | -0.53 | -0.15 | Verrica Pharmaceuticals Non-GAAP EPS of -$0.38 beats by $0.06, revenue of $3.83M beats by $1.18M [5/13/2024 7:45 AM] |
9.48 | 1.48 (18.56%) |
7.60 | -0.40 (-5.00%) |
2.86 - 9.61 | 532,611 | 260,000 | 1,394 | ||
| 29-02-2024 | PM | VRCA | Verrica Pharmaceuticals Inc. | 227.15 | -0.48 | -0.47 | -0.14 | Verrica Pharmaceuticals GAAP EPS of -$0.53 beats by $0.03, revenue of $1.98M beats by $1.03M [2/29/2024 7:40 AM] |
5.33 | -0.39 (-6.82%) |
6.01 | 0.29 (5.02%) |
2.86 - 8.07 | 207,959 | 110,000 | 12,117 | ||
| 09-11-2023 | PM | VRCA | Verrica Pharmaceuticals Inc. | 156.06 | -0.32 | -0.22 | 0.03 | Verrica Pharmaceuticals GAAP EPS of -$0.54 misses by $0.15, revenue of $2.92M beats by $2.45M [11/9/2023 7:36 AM] |
3.21 | -0.35 (-9.83%) |
3.50 | -0.06 (-1.69%) |
2.02 - 8.69 | 230,991 | 110,000 | 8,084 | ||
| 08-08-2023 | PM | VRCA | Verrica Pharmaceuticals | 220.00 | -0.24 | -0.22 | 0.00 | Verrica Pharmaceuticals GAAP EPS of -$0.24 misses by $0.02, revenue of $0.18M beats by $0.11M [8/8/2023 8:01 AM] |
5.28 | 0.15 (2.92%) |
0.0 | 0.0 (0.00%) |
2.02 - 8.69 | 304,130 | 660,000 | 0 | ||
| 09-05-2023 | PM | VRCA | Verrica Pharmaceuticals Inc. | 268.27 | -0.15 | -0.20 | -0.30 | Verrica Pharmaceuticals GAAP EPS of -$0.15 beats by $0.05, revenue of $0.03M misses by $0.61M [5/9/2023 8:50 AM] |
6.54 | -0.08 (-1.21%) |
0.0 | 0.0 (0.00%) |
1.77 - 8.69 | 126,772 | 150,000 | 0 | ||
| 06-03-2023 | PM | VRCA | Verrica Pharmaceuticals | 302.00 | -0.14 | -0.20 | 0.00 | Verrica Pharmaceuticals GAAP EPS of -$0.14 beats by $0.06, revenue of $0.07M [3/6/2023 7:36 AM] |
7.29 | 0.08 (1.18%) |
0.0 | 0.0 (0.00%) |
1.77 - 9.22 | 90,173 | 300,000 | 0 | ||
| 07-11-2022 | AH | VRCA | Verrica Pharmaceuticals | 99.00 | 0.03 | -0.11 | 0.00 | Verrica Pharmaceuticals GAAP EPS of $0.00 beats by $0.14, revenue of $8.3M beats by $4.05M [11/7/2022 4:59 PM] |
2.25 | -0.13 (-5.36%) |
2.30 | -0.08 (-3.36%) |
1.77 - 13.53 | 83,280 | 70,000 | 1,100 | ||
| 11-08-2022 | PM | VRCA | Verrica Pharmaceuticals | 89.00 | -0.36 | -0.32 | 0.00 | Verrica Pharmaceuticals Non-GAAP EPS of -$0.32 in-line, revenue of $0.2M misses by $0.11M [8/11/2022 9:01 AM] |
3.65 | 0.20 (5.80%) |
3.45 | 0.0 (0.00%) |
1.77 - 14.79 | 119,801 | 120,000 | 2,378 | ||
| 02-03-2022 | AH | VRCA | Verrica Pharmaceuticals | 231.00 | -0.35 | -0.48 | 0.00 | Verrica Pharmaceuticals GAAP EPS of -$0.35 beats by $0.14 [3/2/2022 5:01 PM] |
8.62 | 0.03 (0.35%) |
8.59 | 0.0 (0.00%) |
7.10 - 18.42 | 13,399 | 70,000 | 588 | ||
| 12-11-2021 | PM | VRCA | Verrica Pharmaceuticals | 350.00 | -0.46 | -0.49 | 0.00 | Verrica Pharmaceuticals EPS beats by $0.01 [11/12/2021 7:47 AM] |
12.49 | -0.08 (-0.64%) |
12.57 | 0.0 (0.00%) |
8.05 - 18.42 | 41,216 | 40,000 | 1,449 | ||
| 10-08-2021 | PM | 7:30 AM ET (Aug 10) |
VRCA | Verrica Pharmaceuticals Inc. | 291.00 | -0.43 | -0.41 | 0.00 | Verrica Pharmaceuticals EPS in-line [8/10/2021 8:26 AM] |
11.33 | 0.51 (4.71%) |
0.0 | 0.0 (0.00%) |
6.02 - 18.42 | 35,360 | 30,000 | 0 | |
| 07-05-2021 | PM | VRCA | Verrica Pharmaceuticals Inc. | 341.46 | -0.04 | -0.35 | -0.39 | Verrica Pharmaceuticals EPS beats by $0.32 [5/7/2021 7:43 AM] |
11.50 | 0.03 (0.26%) |
12.13 | 0.0 (0.00%) |
6.02 - 18.42 | 84,164 | 70,000 | 418 | ||
| 05-08-2020 | PM | 7:00 AM ET (Aug 5) |
VRCA | Verrica Pharmaceuticals Inc. | 169.34 | -0.38 | -0.45 | -0.28 | Verrica Pharmaceuticals EPS beats by $0.08 [8/5/2020 7:50 AM] |
6.68 | -0.04 (-0.60%) |
6.70 | -0.02 (-0.30%) |
6.13 - 18.67 | 107,104 | 255,702 | 558 | |
|
|
||||||||||||||||||